Polymyxin B

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70594-049
  • Package NDC 70594-049-01
  • Package NDC 70594-049-02
  • Application number ANDA202766
  • SPL ID 809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf
  • SPL set ID b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6
  • UNII 19371312D4
  • RxCUI 204509

What the source publishes

Labeler
Xellia Pharmaceuticals USA LLC
Active ingredients
Polymyxin B Sulfate
Form
INJECTION, POWDER, FOR SOLUTION
Routes
INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, OPHTHALMIC
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70594-049_809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf
{
  "name": "Polymyxin B",
  "splId": "809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf",
  "labels": [
    {
      "setId": "b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6"
    }
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRATHECAL",
    "INTRAVENOUS",
    "OPHTHALMIC"
  ],
  "labeler": "Xellia Pharmaceuticals USA LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (70594-049-01)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS",
      "package_ndc": "70594-049-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20181001"
    },
    {
      "sample": false,
      "description": "10 VIAL, GLASS in 1 CARTON (70594-049-02)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS",
      "package_ndc": "70594-049-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20181001"
    }
  ],
  "productId": "70594-049_809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, FOR SOLUTION",
  "productNdc": "70594-049",
  "deaSchedule": null,
  "genericName": "Polymyxin B Sulfate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "POLYMYXIN B SULFATE",
      "strength": "500000 [USP'U]/1"
    }
  ],
  "applicationNumber": "ANDA202766",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20181001",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0370594049014"
    ],
    "unii": [
      "19371312D4"
    ],
    "rxcui": [
      "204509"
    ],
    "spl_set_id": [
      "b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6"
    ],
    "manufacturer_name": [
      "Xellia Pharmaceuticals USA LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70594-049_809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf"